As of 2024-12-15, the Relative Valuation of Surface Oncology Inc (SURF) is (26.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.07 USD, the upside of Surface Oncology Inc based on Relative Valuation is -2594.5%.
The range of the Relative Valuation is (21.11) - (26.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 17.2x | 16.6x |
| Forward P/E multiples | 7.5x - 19.2x | 18.5x |
| Fair Price | (21.11) - (26.10) | (26.69) |
| Upside | -2072.8% - -2539.0% | -2594.5% |
| Date | P/E |